Camp4 Therapeutics Corporation
CAMP
$2.05
$0.063.02%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 3.03% | 1.44% | |||
| Gross Profit | 3.69% | -1.44% | |||
| SG&A Expenses | 22.97% | 19.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.66% | 5.85% | |||
| Operating Income | -3.83% | -5.85% | |||
| Income Before Tax | 1.52% | -7.75% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.52% | -7.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.52% | -7.75% | |||
| EBIT | -3.83% | -5.85% | |||
| EBITDA | -3.95% | -6.16% | |||
| EPS Basic | 96.82% | 7.96% | |||
| Normalized Basic EPS | 96.82% | 7.96% | |||
| EPS Diluted | 96.82% | 7.96% | |||
| Normalized Diluted EPS | 96.82% | 7.96% | |||
| Average Basic Shares Outstanding | 2,994.73% | 17.05% | |||
| Average Diluted Shares Outstanding | 2,994.73% | 17.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||